CTI class action dismissed
This article was originally published in The Gray Sheet
Executive Summary
Portland, Ore. federal court dismisses class action against Computerized Thermal Imaging. The 2002 suit alleged misrepresentations about the status of a pending PMA for the BCS2100 breast cancer detection system by CTI and former President and COO David Packer (1"The Gray Sheet" June 24, 2002, p. 20). The court ruled that the statements "were either not material, not misleading, or not plead...with sufficient particularity," CTI says...
You may also be interested in...
CTI Class Action Stems From Management Dispute On PMA Submission Timing
Alleged misrepresentations about the status of a pending premarket approval application for Computerized Thermal Imaging, Inc.'s BCS2100 breast cancer detection system are the subject of a recent 1shareholder class action lawsuit against CTI and former President and COO David Packer
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
EU Must Crack Down Harder On Fake Medical Devices, Says Innovator
Counterfeit copies of LifeVac Europe’s anti-choking devices have been registered on the EU’s EUDAMED database and continue to be sold on third-party platforms. Medtech Insight asked director of sales and marketing Matthew Banagan how the company deals with fake devices and what the authorities must do.